Original Research
Accepted on 02 Oct 2024
Tirzepatide, GIP(1-42) and GIP(1-30) display unique signaling profiles at two common GIP receptor variants, E354 and Q354
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 02 Oct 2024
in Experimental Pharmacology and Drug Discovery
Systematic Review
Accepted on 02 Oct 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 02 Oct 2024
in Pediatric Oncology
Original Research
Accepted on 02 Oct 2024
in Translational Pharmacology
Original Research
Accepted on 02 Oct 2024
in Neuro-Otology
Original Research
Accepted on 02 Oct 2024
in Microbe and Virus Interactions with Plants
Clinical Trial
Accepted on 02 Oct 2024
in Health Psychology
Original Research
Published on 02 Oct 2024
in Genitourinary Oncology
Original Research
Published on 02 Oct 2024
in Experimental Endocrinology
Original Research
Published on 02 Oct 2024
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Published on 02 Oct 2024
in Organoids and Organ-On-A-Chip
Original Research
Published on 02 Oct 2024
in Infectious Diseases: Epidemiology and Prevention
Brief Research Report
Published on 02 Oct 2024
in Neuropharmacology
Original Research
Published on 02 Oct 2024
in Ethnopharmacology
Systematic Review
Published on 02 Oct 2024
in Educational Psychology
Original Research
Published on 02 Oct 2024
in Inflammation